{"status": "OK", "response": {"docs": [{"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "Over the past decade, psychiatrists and the news media have proclaimed the wonders of Prozac and the rest of a new generation of antidepressant drugs, known collectively as selective serotonin reuptake inhibitors. Now a report from the United States Department of Health and Human Services has confirmed what has long been an open secret among mental-illness researchers: the S.S.R.I.'s are no more effective at treating depression than older classes of drugs, like tricyclics. Buried within this report is a larger and more disturbing story.", "headline": {"main": "Placebo Nation"}, "abstract": "Op-Ed article by John Horgan notes report from Department of Health and Human Services confirms that during past century, there have been no genuine advances in treatments for depression and other common mental disorders; all therapies, from psychoanalysis to Prozac, are roughly equivalent in their effectiveness, or lack thereof; says report shows those taking placebos and those taking real drugs improve at about same rate, which means that 'scientific' healers are really exploiting power of human belief (M)", "print_page": "15", "word_count": 579, "_id": "4fd209fd8eb7c8105d776520", "snippet": "Over the past decade, psychiatrists and the news media have proclaimed the wonders of Prozac and the rest of a new generation of antidepressant drugs, known collectively as selective serotonin reuptake inhibitors. Now a report from the United States...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/03/21/opinion/placebo-nation.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "PLACEBOS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "PROZAC (DRUG)"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "John", "lastname": "Horgan"}], "original": "By John Horgan"}, "document_type": "article", "pub_date": "1999-03-21T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Executives of Glaxo Wellcome P.L.C., the pharmaceutical giant, said they were delighted to learn earlier this month that an independent study had found that one of their drugs was more effective for people trying to quit smoking than was the nicotine patch. The study crowned a remarkably successful second career for the drug, sustained-release bupropion, which is sold for smoking cessation as Zyban. The drug was introduced in 1997 as an antidepressant, extended-release Wellbutrin. Later that year, the virtually identical drug -- even the same grape color -- was rolled out as Zyban. As Wellbutrin, the drug had $506 million in sales in the United States last year, while as Zyban, it had another $151 million in sales.", "headline": {"main": "New Profits in Old Bottles; Companies Find Bonus in Drugs That Cure Several Ills"}, "abstract": "Article discusses how drug companies, in effort to stretch profits, are developing second and third uses for existing compounds; in one example, Glaxo Wellcome rolled out buproprion as Wellbutrin in February 1997 for depression; company reintroduces it as Zyban in April 1997 as anti-smoking drug; while drug companies need FDA approval before such alternate uses can be cited on drug's label, agency no longer frowns heavily on pharmaceutical companies' promoting ther medications for other uses without FDA approval; photo (M)", "print_page": "1", "word_count": 1745, "_id": "4fd1e9248eb7c8105d737917", "snippet": "Executives of Glaxo Wellcome P.L.C., the pharmaceutical giant, said they were delighted to learn earlier this month that an independent study had found that one of their drugs was more effective for people trying to quit smoking than was the nicotine...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/03/19/business/new-profits-in-old-bottles-companies-find-bonus-in-drugs-that-cure-several-ills.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "GLAXO WELLCOME"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ZYBAN (DRUG)"}, {"name": "subject", "value": "BUPROPION (DRUG)"}, {"name": "subject", "value": "WELLBUTRIN (DRUG)"}], "byline": {"person": [{"firstname": "David", "middlename": "J.", "lastname": "MORROW", "rank": 1, "role": "reported", "organization": ""}], "original": "By DAVID J. MORROW"}, "document_type": "article", "pub_date": "1999-03-19T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A new Government report on antidepressants offers some conclusions that may surprise Prozac Nation, even if they are no surprise to researchers: Prozac and other drugs of its generation are not any better -- or any worse -- than older compounds in treating major depression. The report also sounded a note of caution for physicians who prescribe new antidepressants for children, and for patients who are only mildly depressed: There has not been enough research to establish whether the drugs are effective in either case.", "headline": {"main": "New and Old Depression Drugs Are Found Equal"}, "abstract": "New Government report on antidepressants offers some conclusions that may surprise Prozac Nation, even if they are no surprise to researchers: Prozac and other drugs of its generation are not any better--or any worse--than older compounds in treating depression; report also sounds note of caution for physicians who prescribe new antidepressants for children, and for patients who are only mildly depressed: there has not been enough research to establish whether drug are effective in either case; psychiatrists who specialize in treating depression say report, by Agency for Health Care Policy and Research of Dept of Health and Human Services, will help put to rest assertions that new drugs make older antidepressants obsolete, and skepticism of those who insist that older drugs remain 'gold standard' for treating severe depression (L)", "print_page": "1", "word_count": 965, "_id": "4fd20b7f8eb7c8105d779f9f", "snippet": "A new Government report on antidepressants offers some conclusions that may surprise Prozac Nation, even if they are no surprise to researchers: Prozac and other drugs of its generation are not any better --  or any worse -- than older compounds in...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/03/19/us/new-and-old-depression-drugs-are-found-equal.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "HEALTH AND HUMAN SERVICES DEPARTMENT"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "PROZAC (DRUG)"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Erica", "lastname": "GOODE"}], "original": "By ERICA GOODE"}, "document_type": "article", "pub_date": "1999-03-19T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Every weekday morning around 11 o'clock, a middle-aged stockbroker named Irvin Rosenfeld gets up from his desk and walks to a breezeway outside his office in Boca Raton, Fla. There, alongside the potted palms and smokers taking their breaks, he lights up a cigarette of his own -- not tobacco, but marijuana, sent to him by the Federal Government. The arrangement is 16 years old and perfectly legal. Mr. Rosenfeld, who suffers from a rare bone disorder and smokes to relieve his pain, is part of an exclusive club of Americans who receive a free can of marijuana cigarettes each month under a ''compassionate use'' program sanctioned by the Food and Drug Administration and the National Institute on Drug Abuse.", "headline": {"main": "For a Very Few Patients, U.S. Provides Free Marijuana"}, "abstract": "Comment on exclusive group of Americans who receive free can of marijuana cigarettes each month under 'compassionate use' program sanctioned by FDA and National Institute on Drug Abuse; there are presently only eight participants in program; interview with Irvin Rosenfeld, who for 16 years has been allowed to smoke marijuana to relieve pain of rare bone disorder; question of whether Government should be providing an illegal drug to a chosen few has been thrust into spotlight by new study showing that marijuana is beneficial for certain conditions, including pain, nausea and severe weight loss associated with AIDS; photo of Rosenfeld (L)", "print_page": "10", "word_count": 1223, "_id": "4fd20b7e8eb7c8105d779f9e", "snippet": "Every weekday morning around 11 o'clock, a middle-aged stockbroker named Irvin Rosenfeld gets up from his desk and walks to a breezeway outside his office in Boca Raton, Fla. There, alongside the potted palms and smokers taking their breaks, he...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1999/03/19/us/for-a-very-few-patients-us-provides-free-marijuana.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "ROSENFELD, IRVIN"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "NATIONAL INSTITUTE ON DRUG ABUSE"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "MARIJUANA"}], "byline": {"person": [{"firstname": "Sheryl", "middlename": "Gay", "lastname": "STOLBERG", "rank": 1, "role": "reported", "organization": ""}], "original": "By SHERYL GAY STOLBERG"}, "document_type": "article", "pub_date": "1999-03-19T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 4, "offset": 0, "time": 59}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}